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ABSTRACT. Hybridoma producing monoclonal antibodies (mAbs), specific for three clinically significant
Pseudomonas aeruginosa (serotypes 03, 06, and Oil), were generated to investigate the prevalence of
these serotypes in three Northwestern Ohio hospitals. Fusion products reacting with bacterial cells or
membrane extracts were detected by enzyme-linked-immunosorbent assay (ELISA). Three mAbs desig-
nated: 72C, 11 H (IgM) and HE (IgG2b), were selected. These mAbs reacted with approximately 40% of
the clinical isolates of P. aeruginosa in each hospital. The incidence of serotype Oil varied in these
hospitals, ranging from 13.2%-23.8%. Serotype Oil predominated in two of the three hospitals. The
prevalence of serotype 06 was similar in all three hospitals (13.6-15%). In one of the hospitals (Hospital
2), the occurrence of serotype 06 was slightly higher (15%) than serotype Oil (13-2%). Serotype 03
occurred less frequently (1.5%) in one of the hospitals than in the other two (10-11%). None of the sero-
types showed clear predilection toward any body site. The mAbs did not react with other strains of
P. aeruginosa, nor with other gram-negative or gram-positive organisms. The results of Immuno-
fluorescence and Western blot correlated well with ELISA. However, ELISA showed a higher sensitivity,
indicating the usefulness of this technique for serotyping P. aeruginosa.
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INTRODUCTION
The significance of Pseudomonas aeruginosa as an
opportunistic pathogen has been recognized for many
years (Bodey and others 1983, Olson and others 1984,
Grundmann and others 1993). This organism is respon-
sible for nosocomial infections among patients com-
promised by trauma, burns, respiratory illnesses, surgical
wounds, cancers, and HIV (Singer and others 1977,
McManus and others 1985, Kern and others 1990, Shepp
and others 1994).
The increased prevalence of this multiple-antibiotic-
resistant organism, in many hospitals is alarming. De-
spite the availability of some excellent anti-microbial
agents against P. aeruginosa, the overall mortality and
morbidity have not changed significantly. Thus, a reliable
system for determining the source of infection is neces-
sary to control the spread of this organism.
Various typing methods have been applied to dif-
ferentiate isolates of P. aeruginosa and to determine the
prevalence of the different strains. These methods in-
clude: biotyping, serotyping, bacteriophage typing, pyocin
typing, and antimicrobial susceptibility testing (Bergen
1973, Pitt and Erdman 1977, Pitt 1981, Pitt and others
1986, Pitt 1988, Conroy and others 1983, Patzer and others
1986). In recent years, DNA typing and plasmid profiling
have also been used (Poh and others 1988, Poh and
Yeo 1993, Grundmann and others 1995, Lau and others
1995, Millesimo and others 1996).
Among the various differential characteristics, sero-
typing is used most frequently. This method is repro-
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ducible, easy to perform, and discriminatory (Webster
and Ridgway 1988) The most complete serotyping
system for P. aeruginosa, the International Antigenic
Scheme (IATS), consists of 20 standard 0 serotypes (Liu
and others 1983, Liu and Wang 1990).
Until recently, the slide agglutination technique using
commercially available rabbit polyclonal antisera was
employed for typing P. aeruginosa. Although this is a
simple technique, its application has certain limitations.
For instance, some strains are not typeable, and some are
either autoagglutinable or polyagglutinable, therefore it
can yield unreliable results (Pitt and others 1986). To
enhance the efficiency of serotyping, monoclonal anti-
bodies have been produced and applied for strain
differentiation of P. aeruginosa (Lam, MacDonald and
Lam 1987; Lam, MacDonald, Lam and others 1987). The
application of these reagents has reduced the frequency
of cross-reactivity and improved the overall efficiency of
P. aeruginosa typing (Webster and Ridgeway 1988).
Among the twenty different serotypes of P. aerugin-
osa, only certain members have shown clinical signi-
ficance; the prevalence of these strains varies from one
region to another (Ullman and Schmulling 1980, Farmer
and others 1982). Presently, there is no information
available concerning the prevalence of P. aeruginosa
strains in regional hospitals of Northwestern Ohio. In
addition, the application of ELISA using specific mono-
clonal antibodies in epidemiological studies of P.
aeruginosa has not been described adequately. In the
present investigation, a panel of specific mAbs to three
clinically significant strains of P. aeruginosa (serotypes
03,06 and 011) was produced to investigate their
prevalence in three regional hospitals by ELISA. The
reliability of ELISA was confirmed by IFA and Western
Blotting.
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MATERIALS AND METHODS
Microorganism
Samples of 17 original IATS of P. aeruginosa were ob-
tained from the University of British Columbia (Courtesy
of Dr. R.E.W. Hancock).
The 404 clinical isolates of P. aeruginosa, and other
gram-negative and gram-positive microorganisms, were
obtained from three major regional hospitals for use in
this investigation. The sources of clinical isolates in-
cluded; sputum, urine, wounds, feces, genital secretions,
blood, body fluids, and so forth.
The microorganisms were first propagated on tryptic
soy agar (TSA, Difco) to establish purity. Pure colonies of
each microorganism were grown in tryptic soy broth
(TSB) and aliquots were frozen at -80° C. The micro-
organisms were thawed and propagated on TSA before
each application.
Preparation of Cell Membrane
The procedure of Yang (1982) was used for membrane
preparation. P. aeruginosa (serotypes 03, 06 and Oil)
was propagated in TSB broth and incubated over night
at 35° C. The cells were harvested by centrifugation, sus-
pended in phosphate buffer saline (PBS, pH 7.2); and
disrupted by sonication. The preparations were centri-
fuged at 10,000 X g for 10 min. Then the supernatant
was collected and centrifuged at 40,000 X g for 90 min.
The supernatant was discarded, the pellets were col-
lected, resuspended in PBS and the protein concentration
was determined and adjusted to about 5 mg/ml with the
same buffer. Triton X-100, in 10% (w/v) solution, was
added to a final concentration of 2:1 of the Triton and
protein, respectively. After centrifugation at 40,000 X g
for 1 h, the supernatant was collected and dialyzed
against PBS. Protein concentration was adjusted to 2 mg/
ml and aliquots were frozen at -80° C for future use.
Immunization Procedure
The cell membrane preparation (2 mg protein/ml)
was mixed with an equal volume of complete Freund
adjuvant. BALB/c mice were immunized intramuscularly,
(i.m.), with 0.2 ml of the above mixture. They were
boosted at weekly intervals for eight weeks with the
above preparation without the adjuvant. The last in-
jection was administered intraperitoneally (i.p.) 48 h
before the fusion experiment.
Fusion Experiment
A previously described procedure was used (Jamasbi
and others 1992). BALB/c myeloma cells, SP2/0, were cul-
tivated in Dulbecco's modified Eagle's medium (DMEM)
supplemented with 2|aM//ml L-glutamine, 100 u,g/ml
streptomycin, 100 ui/ml penicillin and 20% fetal bovine
serum. The media and supplements were purchased
from GIBCO Laboratories (Grand Island, NY). On the
day of the experiment, an immunized mouse was sacri-
ficed and its spleen was removed aseptically. A single-cell
suspension was made, and 3 x 107 cells were fused with
5 x 107 myeloma cells. The fusion medium was 45% poly-
ethylene glycol in DMEM. After fusion, the cells were
washed and resuspended in DMEM containing 100 mM
hypoxanthine, 10 mM aminopterin, and 30 mM thymi-
dine (I I AT) medium. The cells were plated at 105 cells/
well in 96 well plates (Corning Inc., Corning, NY), and
incubated at 37° C in an 8% CO., atmosphere with 100%
humidity. At 10 to 14 days after fusion, supernatants of
growing hybridoma cells were assayed for an antibody
to P. aeruginosa using ELISA (see below).
Positive hybridomas were subcultured and tested
against a battery of different bacterial species using
ELISA. Three hybridomas producing specific antipseudo-
monas antibodies were subcultured and cloned by limit-
ing dilution. The cloned hybridomas were expanded and
supernatants were collected. The mAbs were precipitated
from each hybridoma supernatant with 50% ammonium
sulfate, reconstituted in 1/25 of the original volume with
PBS, and dialyzed against PBS three times; the aliquots
were then frozen and stored at -80° (Jamasbi and others
1992). This preparation (1:10-1:100 dilution) was used in
all experiments. The subclass of each mAb was deter-
mined by ELISA using an immunoglobulin typing kit
(Southern Biotechnology Associates, Inc., Birmingham,
AL). The titer of mAbs was determined by preparing
serial dilutions, and ELISA testing.
ELISA Procedure
A modification of a previously employed procedure
was used (Jamasbi, and others 1992). For this purpose,
1 Jig/well of bacterial protein (membrane preparation)
in 50 (il of PBS was added to each well, fixed and
allowed to dry. To perform ELISA, the plates were
washed with PBS; 100 |il of undiluted supernatant, from
hybridoma culture fluids, were added to each well and
incubated at 37° C for 1 h. The wells were washed and
incubated with 100 (il of diluted (1:400) Js-galactosidase-
conjugated goat anti-mouse immunoglobulin (Southern
Biotechnology Associates, Inc., Birmingham, AL). After
1 h incubation at 37° C, the plates were washed, and
100 jil of 1 mg/ml substrate solution (p-nitrophenyl-fs-D-
galactopyranoside) were added to each well, and allowed
to develop at 37° C for 1 h. The optical density was
measured at 410 nm using ELISA plate autoreader, MR-
600 (Dynatech Laboratories, Inc.). When the whole bac-
terial cells were used as antigens, approximately 108
washed bacterial cells in PBS were fixed into each well
and tested by ELISA.
Immunofluorescence Assay (IFA)
Bacterial smears were made, air-dried, heat fixed,
washed and incubated with 100 fil of 1:10 dilution of
each mAb in 1% BSA/PBS for 30 min at 37° C. The slides
were washed and incubated with 100 jil of a 1:50 dilution
of fluorescein isothiocyanate-conjugated rabbit anti-
mouse immunoglobulin (Sigma Chemical Co., St. Louis,
MO) for 30 min at 37° C. The slides were washed and
examined by fluorescence microscopy. A limited number
of direct smears provided by the hospitals were similarly
tested.
Reactivity of mAbs With the Remaining Serotypes
of P. aeruginosa and Other Microorganisms
To determine whether the mAbs reacted with the
remaining serotypes of P. aeruginosa (IATS), bacterial
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cells (different serotypes) were cultured in 96-well plates
and tested by ELISA. The specificity of the mAbs was
further tested by ELISA using other Pseudomonas species
and several other gram-negative (E. coli, E. aerogenes,
Proteus species) and gram-positive (S. aureus, S. faecalis
and Bacillus cereus) organisms.
Gel Electrophoresis and Immunoblotting
Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis was carried out in 10% polyacrylamide
gel (Jamasbi and others 1992). Approximately 20 |ig
solubilized protein/lane were applied. The gel was
subjected to Western transfer (Towbin and others 1979).
Following the transfer, the nitrocellulose membrane was
blocked with 5% non-fat dried milk, washed twice in
washing buffer (150 mM NaCI, 50 mM Tris HCI, pH 7.2
and 0.5% Tween-20), and incubated with the mAb (1:50
dilution) for 1 h at room temperature. The immunoblots
were washed and stained with 1:500 dilution of second-
ary antibody (horseradish peroxidase-conjugated goat
anti-mouse IgG [Sigma]) and reacted with substrate (36
ml, PBS; 12 ml, 3 mg/ml in methanol of 4 chloro-1-
naphthol and 20 u] of H2O2).
RESULTS
Determination of Binding Capacity and Specificity
of Monoclonal Antibodies by P. aeruginosa
Three mAbs, designated 72-C (IgM), 11 E (IgG2b),
and 11 H (IgM), were generated and found to react
specifically with; serotypes 03, 06 and 011, respectively.
The mAbs were tested against 404 clinical isolates of P.
aeruginosa obtained from three Northwestern Ohio
hospitals. Using ELISA, these mAbs reacted with 40.7%,
39-5% and 39-1% of the isolates received from each
hospital (Table 1). The frequency of serotype 06 was not
significantly different in the three participating hospitals
(13-6-15%). However, the incidence of this serotype was
slightly higher (15%) than serotype 011 (13-2%) in hospital
#2. The occurrence of the serotype 011 was different in
the three hospitals, ranging from 13-2% to 23.8% (Table 1),
indicating that the incidence of this serotype differed in
each of the clinical settings. The incidence of the serotype
03 (Table 1) was much lower (1.5%) in one of the hos-
pitals than in the two others (10-11%).
The mAbs did not react with the remaining strains of
IATS serotypes of P. aeruginosa or to any other pseudo-
monas species; nor did they react with any of the other
gram-negative or gram-positive microorganisms (data not
shown), indicating the high degree of specificity of the
mAbs for the corresponding serotype of P. aeruginosa.
Site Distribution
To determine whether any of the three serotypes of
P. aeruginosa, preferentially infect any specific organs,
the frequency of the three serotypes in different ana-
tomical sites were determined (Table 2). Again, serotype
011 showed higher frequency in all anatomical sites
except the ears, where serotype 06 had a slightly higher
occurrence.
Determination of Binding Capacity of Monoclonal
Antibodies by IFA
To determine whether a similar degree of sensitivity
and specificity observed by ELISA, can be achieved by
IFA, direct smears or bacterial smears were stained by
indirect IFA and studied by fluorescence microscopy
(Counts and others 1988). A strong correlation between
ELISA and IFA was obtained. Positive strains of P.
aeruginosa showed strong fluorescence staining (Fig. 1),
while negative strains remained negative (data not
shown). The ELISA method displayed a much higher
degree of sensitivity than the IFA technique. A 1:100
dilution of the mAbs resulted in an optimum ELISA
reading; a dilution of 1:10 of the same mAbs was re-
quired to achieve an optimum IFA result.
Immunoblotting
Immunoblotting experiments were conducted to
determine the specificity and pattern of reactivity of the
mAbs with the soluble membrane antigen extracted
from several positive strains (as determined by ELISA).
The mAbs blotted the corresponding antigens specifically
and produced ladder-like banding profiles on nitro-
cellulose membranes (Lam, MacDonald and Lam 1987;
TABLE 1
































"P. aeruginosa was isolated from different specimens, identified by an established microbiological procedure and serotyped by specific mAbs using KFJSA.
Numbers in parenthesis indicate percentage.
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TABLE 2
Frequency ofserotypes 03, 06 and 011 in different














































































"P. aeruginosa was isolated from different sources, identified by an established
microbiological procedure and serotyped by specific mAbs using ELISA.
^Sputum or tracheal washing.
Lam, MacDonald, Lam and others 1987, Lam and others
1992). For the sake of brevity only one immunoblot is
shown in Figure 2. Again, the results of the immuno-
blotting experiments correlated with the ELISA findings.
DISCUSSION
P. aeruginosa strains account for about 10-11% of all
nosocomial infections (Bennett 1974, Jarvis and Martone
1992). In burn and cancer centers, it is the leading gram-
negative isolate causing 30% of all infections (Cross
1985). Among the twenty different serotypes of P.
aeruginosa, certain members appear to cause the ma-
jority of nosocomial infections. However, the prevalence
of these stains varies from one location to another.
The prevalence of serotype 011 and its association
with the outbreak of infection in different clinical set-
tings have been reported (Yokota and Noguchi 1994,
Hostacka and Majtan 1997). Englender and others (1990)
found serotype 011 to be hospital-acquired and the most
prevalent serotype, accounting for 23% of the isolates.
Orsi and others (1994) recovered 73 environmental and
clinical isolates from a single hospital and found that
serotype 011 was most frequent in the environment,
whereas serotypes 06, 012, 02, and 05 predominated
among clinical isolates. Based on these findings, they con-
cluded that environment was not an important source
of P. aeruginosa infections in their hospital and that
the transfer of the organisms was mainly from patient-
to-patient. Poh and others (1988) reported that the
dominant serotypes in their investigation, were 011
(38%) and 04 (12%).
FIGURE 1. Immunofluorescence assay: A direct smear of a P. aeruginosa
strain was incubated with mAb-11 E (A), or with unrelated mAb (B)
for 30 min at 37° C. The slides were washed and incubated with the
secondary antibody (fluorescein isothiocyanate-conjugated rabbit anti-
body to mouse immunoglobulin) for 30 min. The slides were washed
and examined by a fluorescence microscope (Olymus BH-2). Magnifi-
cation 2,0O0X. Non-specific strain(s) did not stain (data not shown).
Other investigators have found serotype 06 to be the
most frequently detected serotype in their clinical
settings. The high incidence of serotype 06 in pediatric
patients was reported by Ullmann and Schmulling (1980).
Young and Moody (1974) found the presence of sero-
type 06 in 36% of the cases. Pitt (1988) reported that this
serogroup accounts for 21.6% of the strains identified in
the United Kingdom. Patzer and others (1986) found that
serotype 06 and 02 were the most frequently isolated
strains. Bergan (1973) observed 0 serotypes 3 and 6 to be
the most prevalent strains. Brokopp and others (1977)
found 0 serotypes 1, 4, 6, and 11 to be the predominant
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serogroup. Conroy and others (1983) found 44.2% of
P. aeruginosa isolated from bacteremic patients be-
longed either to 01, 06, or Oil. Richet and others (1989)
found serotype 016 to be predominant in hematology
and oncology patients. The above findings, and the
results of the experiments reported here, indicate that
the ecology of P. aeruginosa strains differs in different
regions. However, it appears that serotypes 06 and Oil
are the most frequently encountered strains in many
clinical settings.
The incidence of serotype 03 was 4% and 6% in studies
reported by Legakis and others (1982) and Ojeniyi and
Hoiby (199D, respectively. The high incidence of this
serotype (10-11%) found in two of the hospitals in our
study may suggest nosocomial spread of this serotype.
Of the 404 isolates recovered from the three partici-
pating hospitals, three sites of infection dominated.
Specimens obtained from urine, respiratory secretions
(sputum and tracheal washing), and wounds accounted
for approximately 79% of the strains (Table 2). These are







FIGURE 2. Western blot analysis: Solubilized membrane preparations
(20 |ig protein/lane of P. aeruginosa serotype 06 (lane 1) and two
positive serotype strains from the clinical sources (as determined by
ELISA; lane 2, 3, and one negative strain [lane 4]) were run on SDS-
PAGE under reducing conditions and transferred onto a nitrocellulose
membrane. The membrane was washed, and reacted with mAb-11 E
for 1 h at room temperature. The membrane was washed and further
incubated with horseradish peroxidase-conjugated goat antibody to
mouse immunoglobulin and detected by substrate solution (9 ml of
0.3% 4-chloro-l-naphthol in methanol, 27 ml PBS, pH 7.2 and 15 fil of
30% H2O2). Similar results were obtained under reducing or non-
reducing conditions. Numbers on the left side indicate molecular
weight standards.
infections (Sherertz and Sarubbi 1983). Although, in the
present study, serotype 011 was the most frequently
observed serotype in these organs, no correlation be-
tween the serotypes and site of infection was demon-
strated. Other investigators (Webster and Ridgway 1988)
have reached similar conclusions.
Other methods, such as antimicrobial susceptibility
testing, bacteriocin typing, and phage typing, have been
used to differentiate P. aeruginosa strains. Each of these
typing methods has advantages and disadvantages, but
they can be useful if applied with serotyping. The dis-
advantage of antibiotic susceptibility testing includes
limited sensitivity for highly resistant organisms (such as
P. aeruginosa). Bacteriocin typing lacks standardization
and is not reproducible; the disadvantages of bacterio-
phage typing include lack of standardization, poor
reproducibility, and limited availability of different
bacteriophages (For review see Pfaller 1991).
In recent years newer techniques such as, plasmid
profiling, and DNA typing have been used for strain
differentiation. Plasmid pattern analysis provides a rapid
characterization of bacterial isolates. However, this
technique appears to lack sufficient sensitivity (Poh and
Yeo 1993). Other DNA-based techniques, such as DNA
probe (Grundmann and others 1993) or DNA finger
printing (Grundmann and others 1995, Lau and others
1995), have been applied and found to be superior to
phenotypic typings. It should be noted, however, that
two different DNA typing systems may give conflicting
results (Ojeniyi and Hoiby 1991). The above descriptions
indicate that a single typing method is insufficient for
strain differentiation of P. aeruginosa. By combining
several methods it might be possible to obtain a higher
degree of discrimination between strains. Presently, we
are conducting antibiotic susceptibility tests, biotyping,
plasmid profiling and DNA typing on the positive sero-
types to further substantiate the relatedness or variation
among different strains in the same serogroup.
Regardless of limitation, our data indicate that sero-
typing by specific monoclonal antibodies, using ELISA,
can provide valuable information as a primary screening
method in determining the prevalence of different sero-
types of P. aeruginosa, in various clinical settings.
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